---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-26-000087"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2026-05-26T11:08:51+00:00"
generated_at: "2026-05-26T11:12:52.292203+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cartesian secures up to $150M debt facility; CMO resigns; Phase 3 data expected Q1 2027

## Summary
- Secured up to $150M credit facility with K2 HealthVentures; initial $50M tranche funded at close on May 22, 2026.
- Term loans bear interest at 8.95% or prime+2.20% (whichever greater); matures June 1, 2030 with monthly amortization from July 2029.
- CMO Milos Miljkovic resigns effective May 31, 2026; will receive severance including six months' salary and COBRA coverage.
- Phase 3 AURORA topline data for Descartes-08 in myasthenia gravis expected in Q1 2027; BLA filing planned for mid-2027.
- Cash runway extended into 2028; Phase 2 TRITON and Phase 1/2 HELIOS data expected in H1 2027.

## SEC filing metadata
- accession: 0001453687-26-000087
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2026-05-26T11:08:51+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000087/0001453687-26-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000087/rnac-20260522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-26-000087
- JSON: https://secwatch.observer/filing/0001453687-26-000087.json
- Plain text: https://secwatch.observer/filing/0001453687-26-000087.txt

## Source-grounded claims
- claim_id: 0b672e6ba1
  claim: Milos Miljkovic resigned as Chief Medical Officer at Cartesian Therapeutics, Inc..
  evidence_excerpt: On May 22, 2026, Milos Miljkovic, M.D., the Company’s Chief Medical Officer, delivered a notice of resignation to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000087/0001453687-26-000087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.